Endonucleases
AssigneeBiotec Pharmaconb Asa
InventorsOlav Lanes, Linda Havdalen, Terese Solstad, Marit Lorentzen, Bjørn Altermark, Ingar Leiros, Ronny Helland
Life of this patent
Estimating the term…
Abstract
The present invention provides an endonuclease I or enzymatically active fragment thereof wherein said endonuclease I has the sequence of SEQ ID No. 4 or a sequence which is at least 70% identical thereto and wherein the amino acid residue which is immediately N-terminal of the FYCGC pentapeptide motif has been substituted with a residue which is negatively charged as well as nucleic acid molecules encoding these enzymes and methods of removing contaminating polynucleotides from a sample using these enzyme.
Claims21
An endonuclease I or enzymatically active fragment thereof wherein said endonuclease I has the sequence of SEQ ID No. 4 or a sequence which is at least 70% identical thereto and wherein the amino acid residue which is immediately N-terminal of the FYCGC pentapeptide motif has been substituted with a residue which is negatively charged.
Dependencies are inferred from the claim text.